granted patent: Compositions and methods for promoting hemostasis and other physiological activities

TitleCompositions and methods for promoting hemostasis and other physiological activities
Granted PatentUS 20070203062
Granted Date2007-08-30
Priority Date2006-01-13 US 11/758827P
2005-04-25 US 11/674612P
2006-04-25 US 11/411745
Inventors
Issue Date2007
Citation
US Patent US 20070203062. Washington, DC: US Patent and Trademark Office (USPTO), 2007 How to Cite?
AbstractCompositions that include nanoscale structured materials or precursors thereof (e.g., self-assembling peptides) are described. The compositions can include other substances (e.g., a vasoconstrictor). Also described are methods for using the compositions to promote hemostasis, to protect the skin or wounds from contamination, to decontaminate a site upon removal of previously applied compositions that provided a protective coating, and to inhibit the movement of bodily substances other than blood. The compositions are also useful in isolating tissue, removing tissue, preserving tissue (for, e.g., subsequent transplantation or reattachment), and as bulking, stabilizing or hydrating agents. Medical devices that include the compositions (e.g., a stent or catheter), bandages or other wound dressings, sutures, and kits that include the compositions are also described.
Persistent Identifierhttp://hdl.handle.net/10722/210493
References

 

DC FieldValueLanguage
dc.date.accessioned2015-06-17T07:02:52Z-
dc.date.available2015-06-17T07:02:52Z-
dc.date.issued2007-
dc.identifier.citationUS Patent US 20070203062. Washington, DC: US Patent and Trademark Office (USPTO), 2007-
dc.identifier.urihttp://hdl.handle.net/10722/210493-
dc.description.abstractCompositions that include nanoscale structured materials or precursors thereof (e.g., self-assembling peptides) are described. The compositions can include other substances (e.g., a vasoconstrictor). Also described are methods for using the compositions to promote hemostasis, to protect the skin or wounds from contamination, to decontaminate a site upon removal of previously applied compositions that provided a protective coating, and to inhibit the movement of bodily substances other than blood. The compositions are also useful in isolating tissue, removing tissue, preserving tissue (for, e.g., subsequent transplantation or reattachment), and as bulking, stabilizing or hydrating agents. Medical devices that include the compositions (e.g., a stent or catheter), bandages or other wound dressings, sutures, and kits that include the compositions are also described.-
dc.relation.isreferencedbyUS 2011196326 (A1) 2011-08-11 -
dc.relation.isreferencedbyUS 2010184950 (A1) 2010-07-22 -
dc.relation.isreferencedby A U2009232000 (B2) 2014-12-11-
dc.relation.isreferencedbyAU 2009232000 (A1) 2009-10-08 -
dc.relation.isreferencedbyUS 2011054326 (A1) 2011-03-03-
dc.relation.isreferencedby U S8546338 (B2) 2013-10-01-
dc.relation.isreferencedby U S7696309 (B2) 2010-04-13-
dc.relation.isreferencedbyUS 2012014925 (A1) 2012-01-19 -
dc.relation.isreferencedby U S8741833 (B2) 2014-06-03-
dc.relation.isreferencedby U S8153582 (B2) 2012-04-10-
dc.relation.isreferencedbyUS 2012148674 (A1) 2012-06-14 -
dc.relation.isreferencedbyWO 2013025685 (A1) 2013-02-21-
dc.relation.isreferencedbyUS 2015056263 (A1) 2015-02-26-
dc.relation.isreferencedbyUS 2008095758 (A1) 2008-04-24 -
dc.relation.isreferencedby U S7906478 (B2) 2011-03-15-
dc.relation.isreferencedby U S8828358 (B2) 2014-09-09-
dc.relation.isreferencedby U S8852558 (B2) 2014-10-07-
dc.relation.isreferencedbyUS 2009232877 (A1) 2009-09-17 -
dc.relation.isreferencedbyWO 2009123903 (A1) 2009-10-08-
dc.relation.isreferencedby U S7999067 (B2) 2011-08-16-
dc.relation.isreferencedbyUS 2009036851 (A1) 2009-02-05 -
dc.relation.isreferencedbyUS 2009169521 (A1) 2009-07-02-
dc.relation.isreferencedbyUS 2009232876 (A1) 2009-09-17 -
dc.titleCompositions and methods for promoting hemostasis and other physiological activities-
dc.typePatent-
dc.identifier.authorityTAY DAVID=rp00336-
dc.identifier.authorityELLIS-BEHNKE RUTLEDGE=rp00252-
dc.identifier.authoritySO KWOK-FAI=rp00329-
dc.identifier.authorityLIANG YU-XIANG=rp00510-
dc.description.naturepublished_or_final_version-
dc.contributor.inventorELLIS-BEHNKE RUTLEDGE-
dc.contributor.inventorLIANG YU-XIANG-
dc.contributor.inventorSCHNEIDER GERALD-
dc.contributor.inventorSO KWOK-FAI-
dc.contributor.inventorTAY DAVID-
dc.contributor.inventorZHANG SHUGUANG-
patents.identifier.applicationUS 11/411745-
patents.identifier.grantedUS 20070203062-
patents.description.countryUnited States of America -
patents.date.granted2007-08-30-
dc.relation.references U S8022178 (B2) 2011-09-20-
dc.relation.referencesUS 2009162437 (A1) 2009-06-25 -
patents.identifier.hkutechidAnat-2005-00186-1-
patents.date.application2006-04-25-
patents.date.priority2006-01-13 US 11/758827P-
patents.date.priority2005-04-25 US 11/674612P-
patents.date.priority2006-04-25 US 11/411745-
patents.description.ccus-
patents.relation.familyJP 2008539257 (A) 2008-11-13 -
patents.relation.familyAU 2006241123 (A1) 2006-11-02 -
patents.relation.familyCA 2609656 (A1) 2006-11-02-
patents.relation.familyCN 101267831 (A) 2008-09-17 -
patents.relation.familyDK 1879606 (T3) 2013-09-23-
patents.relation.familyEP 1879606 (A1) 2008-01-23 -
patents.relation.familyEP 2283851 (A2) 2011-02-16 -
patents.relation.familyES 2427565 (T3) 2013-10-31-
patents.relation.familyHK 1112847 (A1) 2014-03-14-
patents.relation.family J P5204646 (B2) 2013-06-05-
patents.relation.familyJP 2011168623 (A) 2011-09-01 -
patents.relation.family J P5629241 (B2) 2014-11-19-
patents.relation.familyJP 2014221830 (A) 2014-11-27-
patents.relation.familyKR 20080007380 (A) 2008-01-18-
patents.relation.familyKR 20100102750 (A) 2010-09-24-
patents.relation.familyUS 2009111734 (A1) 2009-04-30-
patents.relation.familyWO 2006116524 (A1) 2006-11-02-
patents.description.kindA1-
patents.typePatent_granted-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats